Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly

By Fry A.M.   Zell E.R.   Schuchat A.   Butler J.C.   Whitney C.G.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 303-311

Elsevier

Access to resources Recommend Favorite

Potentials and limitations of protein vaccines in infants

By Excler J.-L.  

Vaccine, Vol. 16, Iss. 14, 1998-08 ,pp. : 1439-1443

Elsevier

Access to resources Recommend Favorite

Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines

By Coughlin R.T.   Fattom A.   Chu C.   White A.C.   Winston S.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 17-21

Elsevier

Access to resources Recommend Favorite

Accessory cell defect in unresponsiveness of neonates and aged to polysaccharide vaccines

By Bondada S.   Wu H.-J.   Robertson D.A.   Chelvarajan R.L.  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 557-565

Elsevier

Access to resources Recommend Favorite

Rapid and complete adsorption of unconjugated protein from protein-polysaccharide conjugate vaccines

By Shafer D.E.   Schuman R.F.   Lees A.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1547-1558

Elsevier

Access to resources Recommend Favorite